AQIVLA Trademark

Trademark Overview


On Thursday, September 17, 2015, a trademark application was filed for AQIVLA with the United States Patent and Trademark Office. The USPTO has given the AQIVLA trademark a serial number of 79176972. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 11, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The AQIVLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders * ; all aforementioned goods excluding nutritional supplements, dietary substances and dietetic substances *
aqivla

General Information


Serial Number79176972
Word MarkAQIVLA
Filing DateThursday, September 17, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, November 11, 2022
Registration Number4943818
Registration DateTuesday, April 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 2, 2016

Trademark Statements


Certificate of Correction for RegistrationIn the Statement, line 13 after DISORDERS, "; all aforementioned goods excluding nutritional supplements, dietary substances and dietetic substances" should be inserted.
Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders * ; all aforementioned goods excluding nutritional supplements, dietary substances and dietetic substances *

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events


Event DateEvent Description
Sunday, September 3, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Monday, August 14, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, August 14, 2023INVALIDATION PROCESSED
Tuesday, July 11, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 11, 2022CANCELLED SECTION 71
Friday, August 17, 2018INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Monday, August 6, 2018PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, March 19, 2018LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Thursday, March 15, 2018LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, December 6, 2017LIMITATION FROM THE IB EXAMINED AND ENTERED
Wednesday, December 6, 2017CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, November 3, 2017LIMITATION OF GOODS RECEIVED FROM IB
Friday, August 19, 2016NOTIFICATION PROCESSED BY IB
Friday, May 27, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 27, 2016FINAL DISPOSITION PROCESSED
Thursday, May 26, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 26, 2016REGISTERED-PRINCIPAL REGISTER
Monday, March 21, 2016EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, February 29, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Saturday, February 13, 2016NOTIFICATION PROCESSED BY IB
Tuesday, February 2, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 27, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 13, 2016NOTICE OF PUBLICATION
Tuesday, December 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 29, 2015ASSIGNED TO EXAMINER
Saturday, December 5, 2015APPLICATION FILING RECEIPT MAILED
Tuesday, December 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 27, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 26, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB